Soru

Zorluk: Çok zorDiagnostic Workup and Test Sequencing

A 72-year-old man presents to the clinic with progressive exertional dyspnea, fatigue, and bilateral lower extremity swelling over the past 6 months. He also reports waking up frequently at night due to numbness and a "pins and needles" sensation in both hands, predominantly affecting the thumbs, index, and middle fingers. His medical history is notable for hypertension, for which he takes lisinopril. Blood pressure is 112/70 mm Hg, and pulse is 84/min. Physical examination reveals jugular venous distention to 9 cm H2OH_2O. Lungs are clear to auscultation. Cardiac examination shows a regular rhythm with a prominent S4 gallop; no murmurs are appreciated. Bilateral 2+ pitting edema is present up to the mid-calves.

Electrocardiography demonstrates normal sinus rhythm with first-degree atrioventricular block, low QRS voltage in the limb leads, and QS waves in leads V1 to V3.

Transthoracic echocardiography reveals a left ventricular ejection fraction of 55%, severe concentric left ventricular hypertrophy (interventricular septum thickness of 1.7 cm) with a "sparkling" granular appearance of the myocardium, and severe biatrial enlargement. Doppler evaluation shows a restrictive filling pattern.

Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

  1. A
    Abdominal fat pad fine-needle aspiration
  2. B
    Cardiac magnetic resonance imaging
  3. C
    Endomyocardial biopsy
  4. Serum and urine immunofixation electrophoresis and serum free light chain assayCevap
  5. E
    Technetium-99m pyrophosphate (Tc-99m PYP) cardiac scintigraphy

Cevap

Serum and urine immunofixation electrophoresis and serum free light chain assay
The patient's clinical presentation (heart failure with preserved ejection fraction, carpal tunnel syndrome) and classic diagnostic findings (low ECG voltage discordant with severe left ventricular hypertrophy on echocardiogram, "sparkling" myocardium) are highly suggestive of cardiac amyloidosis. The most critical initial step in the diagnostic sequence for suspected cardiac amyloidosis is to screen for a monoclonal plasma cell dyscrasia to rule out primary light chain (AL) amyloidosis. This is achieved by ordering a serum free light chain assay combined with both serum and urine immunofixation electrophoresis. AL amyloidosis is a hematologic emergency that requires prompt chemotherapy. If this screening panel is completely negative, the next appropriate step is bone scintigraphy (e.g., Tc-99m PYP) to evaluate for transthyretin (ATTR) amyloidosis non-invasively.

Adım Adım Çözüm

1
Analyze the clinical presentation and diagnostic findings.
The patient's symptoms of heart failure with preserved ejection fraction, concurrent carpal tunnel syndrome, and discordant ECG (low voltage) and echocardiogram (severe LVH, sparkling myocardium) findings strongly suggest cardiac amyloidosis.
Recognizing the classic clinical syndrome of cardiac amyloidosis is the prerequisite for initiating the correct diagnostic pathway.
2
Determine the critical branch point in testing.
The first priority is to screen for a monoclonal plasma cell dyscrasia to differentiate between AL (light chain) and ATTR (transthyretin) amyloidosis.
AL amyloidosis is a hematologic malignancy that is rapidly fatal if untreated. It can also mimic ATTR amyloidosis on non-invasive imaging, necessitating immediate laboratory rule-out.
3
Select the appropriate tests for monoclonal protein screening.
A serum free light chain assay combined with serum and urine immunofixation electrophoresis is selected.
This combination of laboratory tests provides a >99% sensitivity for detecting the monoclonal protein associated with AL amyloidosis, safely guiding subsequent imaging or biopsy decisions.

Anahtar Kavram

Diagnostic sequencing of suspected cardiac amyloidosis requires screening for monoclonal proteins (AL amyloidosis) before or concurrently with non-invasive bone scintigraphy (ATTR amyloidosis).
Tahmini Süre:1m 30s
Bu soruyu puanla